Sirnaomics is a clinical stage biopharmaceutical company leveraging an outstanding level of knowledge and experience in RNA interference (RNAi) technology to forge a path to high value creation through discovery and development of therapeutics for human disorders with unmet medical needs.

Pharmaceutical

Sirnaomics

Sirnaomics' headquarters in Gaithersburg, MD, United States

Patrick Y. Lu

Jason Lok

Jacqueline A. Dombroski

Dai Xiaochang

Nigel Yip

Edward Wang

Xianbin Yang

The Leadership Team at Sirnaomics is responsible for guiding the company's strategic direction and ensuring operational excellence in the development of RNAi-based therapeutics. This team, composed of senior executives from various functions such as regulatory compliance, operations, scientific research, and finance, collaborates to align the company's goals with its mission of addressing unmet medical needs while navigating the complex landscape of clinical development and commercialization.

Leadership Team

The Finance Team at Sirnaomics is responsible for managing the company's financial planning, analysis, and accounting functions. They ensure the efficient allocation of resources to support the development of innovative RNAi therapeutics, while overseeing budgeting, forecasting, and reporting to maintain financial health and compliance. The team plays a critical role in strategic decision-making to drive value creation and support the company's growth objectives in the biopharmaceutical sector.

Finance Team

The Regulatory and Compliance team at Sirnaomics is responsible for ensuring that all therapeutic developments adhere to regulatory standards and guidelines. This includes overseeing quality assurance processes, preparing submissions for regulatory approvals, and liaising with regulatory bodies to facilitate compliance with local and international regulations. Their work is critical in navigating the complex landscape of biopharmaceutical regulations to bring innovative RNAi-based therapies to market.

Regulatory and Compliance

This department focuses on defining and implementing strategic initiatives to drive organizational growth.

Strategy Development

This department oversees clinical operations and regulatory compliance to ensure the safe development and approval of medical products.

Clinical and Regulatory Affairs

The Research and Development team at Sirnaomics is dedicated to advancing innovative RNA interference (RNAi) therapeutics. This team conducts cutting-edge research, designs and optimizes delivery mechanisms, and oversees clinical trial methodologies to ensure the effective development of treatments targeting unmet medical needs. Their collaborative efforts aim to translate scientific discoveries into viable therapeutic options for patients.

Sirnaomics

Org chart

Teams

Leadership Team

Finance Team

Regulatory and Compliance

Strategy Development

Clinical and Regulatory Affairs

Research and Development

Offices

Sirnaomics

Org chart

Teams

Leadership Team

Finance Team

Regulatory and Compliance

Strategy Development

Clinical and Regulatory Affairs

Research and Development

Offices

Related companies